Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome
Top Cited Papers
- 1 September 2020
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 173 (5), 350-361
- https://doi.org/10.7326/m20-2566
Abstract
The clinicopathological basis for morbidity and mortality with SARS-CoV-2 infection is not well understood. This study reports the clinical and autopsy findings of patients who died of COVID-19. Background: Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become pandemic, with substantial mortality. Objective: ...This publication has 53 references indexed in Scilit:
- Liver Injury and Failure in Critical IllnessHepatology, 2019
- CT-based weight assessment of lung lobes: comparison with ex vivo measurementsDiagnostic and Interventional Radiology, 2013
- Why are the high altitude inhabitants like the Tibetans shorter and lighter?Medical Hypotheses, 2008
- What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients?Medical Hypotheses, 2008
- Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathwaysThe Journal of Pathology, 2004
- Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis.Archives of Pathology & Laboratory Medicine, 2004
- Lung pathology of fatal severe acute respiratory syndromeThe Lancet, 2003
- Coagulation, fibrinolysis, and fibrin deposition in acute lung injuryCritical Care Medicine, 2003
- Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzymeFEBS Letters, 2002
- The pulmonary vascular lesions of the adult respiratory distress syndrome.1983